Literature DB >> 27374456

The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma.

Naoki Yanagawa1, Satoshi Shiono2, Masami Abiko2, Masato Katahira2, Mitsumasa Osakabe3, Shin-Ya Ogata3.   

Abstract

INTRODUCTION: Since the new adenocarcinoma (ADC) classification was presented in 2011, several authors have reported that patients with solid (S) and/or micropapillary (MP) predominant patterns showed a worse prognosis. On the other hand, there are several patients who have S and/or MP patterns even if their patterns are not predominant. However, the evaluation of these patients is uncertain.
METHODS: A total of 531 ADCs were examined. We classified the patients into five subgroups according to the proportion of S and/or MP patterns: (1) both patterns absent (S-/MP-), (2) S predominant (S pre), (3) MP predominant (MP pre), (4) S pattern present although not predominant and MP pattern absent (S+ not pre/MP-), and (5) MP pattern present although not predominant (MP+ not pre).
RESULTS: Of the 531 ADCs, 384 (72.3%) were classified as S-/MP-, 55 (10.4%) as S pre, 11 (2.1%) as MP pre, 42 (7.9%) as S+ not pre/MP-, and 39 (7.3%) as MP+ not pre. In a univariate analysis, the recurrence-free survival (RFS) and overall survival differed significantly among the five subgroups (p < 0.01 and p < 0.01, respectively). In a multivariate analysis, patients with S-/MP- had significantly higher RFS rates than did those with other subgroups. On the other hand, patients with MP pre had lower RFS rates than did those with other subgroups.
CONCLUSION: Patients with S and/or MP patterns have a poorer prognosis even if their patterns are not predominant. The S and/or MP patterns must be treated at the time of diagnosis.
Copyright © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung adenocarcinoma; Micropapillary pattern; Prognosis; Solid pattern

Mesh:

Year:  2016        PMID: 27374456     DOI: 10.1016/j.jtho.2016.06.014

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  30 in total

1.  Prognostic contribution of non-predominant solid and micropapillary components in lung adenocarcinomas.

Authors:  Masaki Suzuki; Tomoyuki Yokose; Haruhiko Nakayama
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  A complicated clinical problem: surgical treatment decisions for patients with early-stage lung cancer.

Authors:  Jianfei Shen; Yang Liu; Chengyang Dai; Baofu Chen; Chang Chen; Gaetano Rocco; Alessandro Brunelli; Chia-Chuan Liu; Rene Horsleben Petersen; Jianxing He
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.

Authors:  Yiyang Wang; Difan Zheng; Jiajie Zheng; Qingyuan Huang; Baohui Han; Jie Zhang; Heng Zhao; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-12       Impact factor: 4.553

5.  Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma.

Authors:  Jung-Soo Pyo; Joo Heon Kim
Journal:  Pathol Oncol Res       Date:  2017-07-06       Impact factor: 3.201

6.  The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.

Authors:  Tamás Zombori; Tibor Nyári; László Tiszlavicz; Regina Pálföldi; Edit Csada; Tibor Géczi; Aurél Ottlakán; Balázs Pécsy; Gábor Cserni; József Furák
Journal:  Virchows Arch       Date:  2018-04-02       Impact factor: 4.064

7.  Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.

Authors:  Cheng Chang; Xiaoyan Sun; Wenlu Zhao; Rui Wang; Xiaohua Qian; Bei Lei; Lihua Wang; Liu Liu; Maomei Ruan; Wenhui Xie; Junkang Shen
Journal:  Radiol Med       Date:  2019-12-10       Impact factor: 3.469

8.  Prognosis of limited resection versus lobectomy in elderly patients with invasive lung adenocarcinoma with tumor size less than or equal to 2 cm.

Authors:  Tianxiang Chen; Jizhuang Luo; Rui Wang; Haiyong Gu; Yu Gu; Qingyuan Huang; Yiyang Wang; Jiajie Zheng; Yunhai Yang; Heng Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

9.  Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma.

Authors:  Minjie Ma; Yunlang She; Yijiu Ren; Chenyang Dai; Lei Zhang; Huikang Xie; Chunyan Wu; Minglei Yang; Dong Xie; Chang Chen
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

10.  Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors.

Authors:  Yiyang Wang; Difan Zheng; Jizhuang Luo; Jie Zhang; Cecilia Pompili; Hideki Ujiie; Natsumi Matsuura; Haiquan Chen; Feng Yao
Journal:  Transl Lung Cancer Res       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.